| abstract |
The present invention provides a novel RAR selective retinoid agonist of formula (I), wherein the symbols are defined herein, pharmaceutically acceptable salts thereof, isomers or racemates or non-racemate mixtures thereof; Pharmaceutical compositions containing them, and methods for using them as therapeutics:n n n [Formula I]n n n . |